Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Salarius Pharmaceuticals Inc SLRX

Healthcare Biotechnology
Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing treatments for parties with cancers in need of new treatment options. Its product portfolio includes seclidemstat, an oral novel small molecule inhibitor of the LSD1 enzyme and the Company's lead candidate, which is being studied as a potential treatment for pediatric cancers, sarcomas, and... see more

Recent & Breaking News (NDAQ:SLRX)

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Flex Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire June 20, 2018

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Regarding Whether the Sale of First Connecticut Bancorp, Inc. to People’s United Financial, Inc. is Fair to Shareholders

Business Wire June 20, 2018

INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Flex Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire June 19, 2018

Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Flex Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline – FLKS

GlobeNewswire June 19, 2018

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Nationstar Mortgage Holdings Inc. (NSM) & Lead Plaintiff Deadline – July 30, 2018

GlobeNewswire June 19, 2018

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against TAL Education Group – TAL

Business Wire June 19, 2018

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Flex Pharma, Inc.

Business Wire June 14, 2018

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Flex Pharma, Inc. - FLKS

Canada NewsWire June 13, 2018

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Guess?, Inc. (GES)

PR Newswire June 13, 2018

Flex Pharma Announces Corporate Update

Business Wire June 13, 2018

Flex Pharma Reports First Quarter 2018 Financial Results

Business Wire May 2, 2018

Flex Pharma to Report First Quarter 2018 Financial Results on May 2, 2018

Business Wire April 25, 2018

Flex Pharma Reports Positive Topline Data from Exploratory Phase 2 Trial of FLX-787 in Multiple Sclerosis

Business Wire March 26, 2018

These stocks are trending right now: Big Lots, Flex Pharma, Medifast, Netflix and US Steel

PR Newswire March 9, 2018

Flex Pharma, Inc. to Host Earnings Call

Accesswire March 7, 2018

Flex Pharma Reports Year End 2017 Financial Results

Business Wire March 7, 2018

Flex Pharma to Report Fourth Quarter and Full Year 2017 Results on March 7, 2018

Business Wire February 28, 2018

New Study Shows HOTSHOT™ Provides Relief From Muscle Soreness For Athletes Of All Types

PR Newswire February 8, 2018

Flex Pharma Presenting at BIO CEO on February 13, 2018

Business Wire February 6, 2018

Enrollment Completed in Flex Pharma’s Phase 2 Exploratory Spasticity Study in MS

Business Wire November 28, 2017